Nicolas S. Piuzzi, M.D. – FDA Inspection, Mar 27, 2026

Record Details

This FDA Inspection record concerns Nicolas S. Piuzzi, M.D., with an inspection on March 27, 2026, issued by the Cincinnati District Office, covering human drugs.

Company: Nicolas S. Piuzzi, M.D.
Inspection Date: March 27, 2026
Product Type: Human Drugs
Office: Cincinnati District Office
Person: D'Arbra R. Blankenship (Issuing Officer)

View Company Profile

ID · b8a77eda-0c06-4bc0-b3f0-d06b927c6f8f

Inspection Facts

Inspection number: 1309586
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.64(b)Safety Reports - Non-Serious Events
21 CFR 312.64(b)Safety Reports - Serious Events

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nicolas S. Piuzzi, M.D.

FDA Inspection

Nicolas S. Piuzzi, M.D.March 27, 2026